The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells

Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor

(2014) Valerio Chiurchiù et al.   ATHEROSCLEROSIS

Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis

(2013) Valerio Chiurchiù et al.   ANNALS OF NEUROLOGY

Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition

(2013) Eric O. Long et al.   Annual Review of Immunology

GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors

(2013) V. Gasperi et al.   CURRENT MEDICINAL CHEMISTRY

Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation

(2013) Slava Rom et al.   Journal of Neuroimmune Pharmacology

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation

(2013) Ismael Galve-Roperh et al.   PROGRESS IN LIPID RESEARCH

A potential role for GPR55 in gastrointestinal functions

(2012) Rudolf Schicho et al.   CURRENT OPINION IN PHARMACOLOGY

Unknown

(2012) Fernando Souza-Fonseca-Guimaraes et al.   MOLECULAR MEDICINE

The role of CB1 in immune modulation by cannabinoids

(2012) Barbara L.F. Kaplan   PHARMACOLOGY & THERAPEUTICS

Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells

(2011) Giuseppina Cantarella et al.   BIOCHEMICAL PHARMACOLOGY

GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils

(2011) Nariman A B Balenga et al.   CELL RESEARCH

Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55

(2011) Christopher M. Henstridge et al.   MOLECULAR ENDOCRINOLOGY

Modulation of the novel cannabinoid receptor - GPR55 - during rat fetoplacental development

(2011) B.M. Fonseca et al.   PLACENTA

Nomenclature of monocytes and dendritic cells in blood

(2010) L. Ziegler-Heitbrock et al.   BLOOD

Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55?

(2010) W-SV Ho   BRITISH JOURNAL OF PHARMACOLOGY

The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment

(2010) Rudolf Schicho et al.   INFLAMMATORY BOWEL DISEASES

Altered miRNA expression in T regulatory cells in course of multiple sclerosis

(2010) Giuseppe De Santis et al.   JOURNAL OF NEUROIMMUNOLOGY

The putative cannabinoid receptor GPR55 promotes cancer cell proliferation

(2010) G Hu et al.   ONCOGENE

Pharmacological characterization of GPR55, a putative cannabinoid receptor

(2010) Haleli Sharir et al.   PHARMACOLOGY & THERAPEUTICS

Anandamide Suppresses Proliferation and Cytokine Release from Primary Human T-Lymphocytes Mainly via CB2 Receptors

(2010) Maria Teresa Cencioni et al.   PLoS One

Selective CB2 Receptor Agonism Protects Central Neurons from Remote Axotomy-Induced Apoptosis through the PI3K/Akt Pathway

(2009) M. T. Viscomi et al.   JOURNAL OF NEUROSCIENCE

The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo

(2009) L. S. Whyte et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The enigmatic pharmacology of GPR55

(2009) Ruth A. Ross   TRENDS IN PHARMACOLOGICAL SCIENCES

Up on the tightrope: natural killer cell activation and inhibition

(2008) Lewis L Lanier   NATURE IMMUNOLOGY

NK cells and cancer immunosurveillance

(2008) I Waldhauer et al.   ONCOGENE

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

(2008) Penny C. Staton et al.   PAIN

GPR55 and the vascular receptors for cannabinoids

(2007) C R Hiley et al.   BRITISH JOURNAL OF PHARMACOLOGY

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects

(2007) D G Johns et al.   BRITISH JOURNAL OF PHARMACOLOGY